IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
36.01
+0.08 (0.22%)
At close: Jul 17, 2026, 4:00 PM EDT
36.50
+0.49 (1.36%)
After-hours: Jul 17, 2026, 4:15 PM EDT

IDEAYA Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4243,0352,2232,314876911
Market Cap Growth
76.50%36.52%-3.93%164.27%-3.87%120.28%
Enterprise Value
2,4802,4241,5661,792514.32669.33
Last Close Price
36.0134.5725.7035.5818.1723.64
Forward PE
-68.3668.3668.3668.3668.36
PS Ratio
15.2013.88317.5998.9617.1932.60
PB Ratio
3.382.972.103.732.513.02
P/TBV Ratio
3.412.991.983.302.152.76
EV/Sales Ratio
11.0111.08223.7176.6210.1023.96
Debt / Equity Ratio
0.030.030.020.000.000.01
Net Debt / Equity Ratio
-0.69-0.60-0.62-0.84-1.03-0.80
Net Debt / EBITDA Ratio
3.593.952.034.006.135.12
Net Debt / FCF Ratio
7.318.322.614.443.994.14
Asset Turnover
-0.200.010.050.130.08
Quick Ratio
10.3510.8714.6819.3811.515.49
Current Ratio
10.7411.3414.9719.6511.685.56
Return on Equity (ROE)
-14.29%-10.92%-32.67%-23.28%-18.02%-19.91%
Return on Assets (ROA)
-17.15%-14.27%-36.88%-25.92%-16.25%-14.79%
Return on Invested Capital (ROIC)
-47.19%-36.31%-118.23%-195.08%-82.55%-70.18%
Return on Capital Employed (ROCE)
-18.20%-14.97%-38.46%-27.48%-18.05%-16.87%
Buyback Yield / Dilution
-4.21%-8.33%-42.00%-38.79%-17.57%-42.60%
Total Shareholder Return
-4.21%-8.33%-42.00%-38.79%-17.57%-42.60%
SEC Filings: 10-K · 10-Q